Pre-made Omalizumab benchmark antibody ( Whole mAb, anti-IGHE/IgE therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	List Price(In USD)	Discount off	Discount Price
GMP-Bios-ab-398-1mg	1mg	3090	Inquiry	Inquiry

Size： 1mg | 10mg | 100mg

Description

Products Name (INN Index)	Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody
INN Name	Omalizumab
Target	IGHE
Format	Whole mAb
Derivation
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Approved
Est. Status	Active
100% SI Structure	4x7s:HL/2xa8:HL/4x7t:HL:AB/5hys:HL:AB:EF:CD/6tcm:HL/6tcn:HL/6tco:BA/6tcp:HL
99% SI Structure	5g64:IM:HL
95-98% SI Structure	None
Year Proposed	2000
Year Recommended	2001
Companies	Dana-Farber Cancer Institute;Genentech;John Hopkins University;Novartis
Conditions Approved	Allergic asthma;Urticaria
Conditions Active	Seasonal allergic rhinitis;Nasal polyps;Mastocytosis;Asthma;Nephritis
Conditions Discontinued	Hypersensitivity;Peanut hypersensitivity
Development Tech	na